Download Citation
Article Source:
A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy
Lee SJ,
Shin SJ,
Lee MH,
Lee MG,
Kang TH,
et al.
(2014)
A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy.
PLOS ONE 9(8): e104351.
https://doi.org/10.1371/journal.pone.0104351